Cargando…

BNP as a Major Player in the Heart-Kidney Connection

Brain natriuretic peptide (BNP) is an important biomarker for patients with heart failure, hypertension and cardiac hypertrophy. Although it is known that BNP levels are relatively higher in patients with chronic kidney disease and no heart disease, the mechanism remains unknown. Here, we review the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okamoto, Ryuji, Ali, Yusuf, Hashizume, Ryotaro, Suzuki, Noboru, Ito, Masaaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678680/ https://www.ncbi.nlm.nih.gov/pubmed/31336656 http://dx.doi.org/10.3390/ijms20143581

Ejemplares similares

Renal papillary tip extract stimulates BNP production and excretion from cardiomyocytes
por: Goto, Itaru, et al.
Publicado: (2018)

Serum-Induced Expression of Brain Natriuretic Peptide Contributes to Its Increase in Patients with HFpEF
por: Okamoto, Ryuji, et al.
Publicado: (2022)

Direct Immunochemiluminescent Assay for proBNP and Total BNP in Human Plasma proBNP and Total BNP Levels in Normal and Heart Failure
por: Nishikimi, Toshio, et al.
Publicado: (2013)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
por: Alawieh, Hussein, et al.
Publicado: (2019)

Gap junction protein beta 4 plays an important role in cardiac function in humans, rodents, and zebrafish
por: Okamoto, Ryuji, et al.
Publicado: (2020)

B-Type Natriuretic Peptide (BNP) Revisited—Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?
por: Nishikimi, Toshio, et al.
Publicado: (2022)

A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
por: Linssen, G. C. M., et al.
Publicado: (2018)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
por: Cao, Zhipeng, et al.
Publicado: (2019)

Doppler Echocardiography Combined with NTproBNP/BNP in the Diagnosis of Pulmonary Artery Hypertension Associated with Congenital Heart Disease
por: Zhang, Xi, et al.
Publicado: (2023)

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
por: Sweeney, Claire, et al.
Publicado: (2021)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

Prediction of cardiac events using fully automated GLS and BNP titers in patients with known or suspected heart failure
por: Otani, Kyoko, et al.
Publicado: (2020)

The Potential Role of Salivary NT-proBNP in Heart Failure
por: Rammos, Aidonis, et al.
Publicado: (2023)

Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta‐analysis
por: Hendricks, Stefanie, et al.
Publicado: (2022)

Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
por: Kerr, Brian, et al.
Publicado: (2022)

The Ratio of NT-proBNP to CysC(1.53) Predicts Heart Failure in Patients With Chronic Kidney Disease
por: Wang, Sheng, et al.
Publicado: (2021)

Using NT-proBNP as a criterion for heart failure hospitalization
por: Tamizifar, Babak, et al.
Publicado: (2012)

Impact of high intensity interval and moderate continuous training on plasma ratios of ProBNP(1-108)/BNP(1-32) and NT-pro-BNP(1-76)/BNP(1-32) after coronary artery bypass grafting surgery
por: Zare Karizak, Sara, et al.
Publicado: (2023)

NT-proBNP and postoperative heart failure in surgery for aortic stenosis
por: Jiang, Huiqi, et al.
Publicado: (2019)

Clinical value of BNP as an independent predictor of mortality following heart surgery
por: Gabriel, Edmo Atique
Publicado: (2015)

The relationship between NT-proBNP and Depression in Patients with Heart Failure
por: Gao, Ying–Hui, et al.
Publicado: (2017)

Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure
por: Li, Zhiyong, et al.
Publicado: (2022)

The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008)

Risk factors for pre‐heart failure or symptomatic heart failure based on NT‐proBNP
por: Aoki, Shoko, et al.
Publicado: (2022)

The association of plasma NT-proBNP level and progression of diabetic kidney disease
por: Zhao, Yuancheng, et al.
Publicado: (2023)

NT-proBNP: A Guide to Improve the Management of Patients with Heart Failure
por: Latini, Roberto, et al.
Publicado: (2014)

Can restoration of heart rate in ESRD lower BNP? A case report
por: Mohamed, Mahmoud M., et al.
Publicado: (2021)

NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
por: Komarnicki, Paweł, et al.
Publicado: (2023)

Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
por: Chanmee, Theerawut, et al.
Publicado: (2014)

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)
por: Maries, Lorena, et al.
Publicado: (2013)

The evaluation of the clinical utility of urocortin 1 and adrenomedullin versus proBNP in systolic heart failure
por: Yıldırım, Erkan, et al.
Publicado: (2017)

NT-ProBNP Levels in Saliva and Its Clinical Relevance to Heart Failure
por: Foo, Jared Yong Yang, et al.
Publicado: (2012)

Chronic heart failure treatment benefits from pro-BNP-directed therapy
por: J, Aalbers
Publicado: (2011)

NT-proBNP test with improved accuracy for the diagnosis of chronic heart failure
por: Pan, Yesheng, et al.
Publicado: (2017)

The Use of N-Terminal-Pro-BNP in Preterm Infants
por: EL-Khuffash, Afif, et al.
Publicado: (2009)

The pro-BNP Serum Level and Echocardiographic Tissue Doppler Abnormalities in Patients with Beta Thalassemia Major
por: Garadah, Taysir S., et al.
Publicado: (2010)

Cardiopulmonary exercise testing and NT-proBNP before major vascular surgery: do they correlate?
por: Turley, A, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_cn47a3t26as659uls7vbfqsqg9